Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 117,483 | 120,368 | 92,008 | 71,953 | 65,085 |
| Cost of Goods | 41,455 | 36,523 | 33,078 | 28,195 | 25,462 |
| Gross Profit | 76,028 | 83,845 | 58,930 | 43,758 | 39,623 |
| Operating Expenses | 111,872 | 99,495 | 81,241 | 70,491 | 68,888 |
| Operating Income | -35,389 | -15,127 | -22,233 | -26,538 | -28,803 |
| Interest Expense | 0 | 0 | 1,963 | 4,941 | 2,757 |
| Other Income | 480 | 2,528 | 1,197 | 476 | 202 |
| Pre-tax Income | -34,909 | -12,599 | -22,999 | -31,003 | -31,358 |
| Net Income Continuous | -34,909 | -12,599 | -22,999 | -31,003 | -31,358 |
| Net Income | $-34,909 | $-12,599 | $-22,999 | $-31,003 | $-31,358 |
| EPS Basic Total Ops | -0.66 | -0.27 | -0.62 | -0.91 | -1.09 |
| EPS Basic Continuous Ops | -0.66 | -0.27 | -0.62 | -0.91 | -1.09 |
| EPS Diluted Total Ops | -0.66 | -0.27 | -0.62 | -0.91 | -1.09 |
| EPS Diluted Continuous Ops | -0.66 | -0.27 | -0.62 | -0.91 | -1.09 |
| EPS Diluted Before Non-Recurring Items | -0.66 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-27,445 | $-10,927 | $-18,281 | $-22,225 | $-26,067 |